These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11176102)

  • 1. Rhabdomyolysis following cardiopulmonary bypass and treatment with enoximone in a patient susceptible to malignant hyperthermia.
    Riess FC; Fiege M; Moshar S; Bergmann H; Bleese N; Kormann J; Weisshorn R; Wappler F
    Anesthesiology; 2001 Feb; 94(2):355-7. PubMed ID: 11176102
    [No Abstract]   [Full Text] [Related]  

  • 2. Massive rhabdomyolysis following cardiopulmonary bypass.
    Cone AM; Schneider M
    Anaesth Intensive Care; 1995 Dec; 23(6):721-4. PubMed ID: 8669609
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro and in vivo effects of the phosphodiesterase-III inhibitor enoximone on malignant hyperthermia-susceptible swine.
    Fiege M; Wappler F; Weisshorn R; Gerbershagen MU; Kolodzie K; Schulte Am Esch J
    Anesthesiology; 2003 Apr; 98(4):944-9. PubMed ID: 12657857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis of susceptibility to malignant hyperthermia with an in vitro contracture test with the phosphodiesterase iii inhibitor enoximone].
    Fiege M; Wappler F; Scholz J; von Richthofen V; Brinken B; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Sep; 33(9):557-63. PubMed ID: 9787864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhabdomyolysis after infection and taking a cold medicine in a patient who was susceptible to malignant hyperthermia.
    Kasamatsu Y; Osada M; Ashida K; Azukari K; Yoshioka K; Ohsawa A
    Intern Med; 1998 Feb; 37(2):169-73. PubMed ID: 9550599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Massive postoperative rhabdomyolysis after uneventful surgery: a case report of subclinical malignant hyperthermia.
    Harwood TN; Nelson TE
    Anesthesiology; 1998 Jan; 88(1):265-8. PubMed ID: 9447881
    [No Abstract]   [Full Text] [Related]  

  • 7. Weaning from cardiopulmonary bypass. Theory and practice.
    Jessup M
    Chest; 1990 Jul; 98(1):7-9. PubMed ID: 2141812
    [No Abstract]   [Full Text] [Related]  

  • 8. Prophylactic use of the phospodiesterase III inhibitor enoximone in elderly cardiac surgery patients: effect on hemodynamics, inflammation, and markers of organ function.
    Boldt J; Brosch C; Suttner S; Piper SN; Lehmann A; Werling C
    Intensive Care Med; 2002 Oct; 28(10):1462-9. PubMed ID: 12373472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative severe rhabdomyolysis revealing susceptibility to malignant hyperthermia.
    Fierobe L; Nivoche Y; Mantz J; Elalaoui Y; Veber B; Desmonts JM
    Anesthesiology; 1998 Jan; 88(1):263-5. PubMed ID: 9447880
    [No Abstract]   [Full Text] [Related]  

  • 10. Malignant hyperthermia as a cause for postoperative rhabdomyolysis.
    Wappler F; Fiege M
    Anesthesiology; 2000 Apr; 92(4):1206-7. PubMed ID: 10754651
    [No Abstract]   [Full Text] [Related]  

  • 11. Can we prevent malignant hyperthermia after hypothermic cardiopulmonary bypass in a malignant hyperthermia-susceptible patient?
    Siddik-Sayyid SM; Moussa AR; Baraka AS
    Anesth Analg; 2007 Jan; 104(1):214; author reply 214-5. PubMed ID: 17179280
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of a new inotropic agent, enoximone, in heart surgery].
    Gomar C; Fita G; Pomar JL; Valero R; Mulet J; Nalda MA
    Rev Esp Anestesiol Reanim; 1991; 38(2):121-6. PubMed ID: 1678896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiopulmonary bypass in malignant hyperthermia susceptible patients: a systematic review of published cases.
    Metterlein T; Zink W; Kranke E; Haneya A; Graf B; Kranke P
    J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1488-95. PubMed ID: 21376345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhabdomyolysis following severe physical exercise in a patient with predisposition to malignant hyperthermia.
    Köchling A; Wappler F; Winkler G; Schulte am Esch JS
    Anaesth Intensive Care; 1998 Jun; 26(3):315-8. PubMed ID: 9619231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory response to cardiopulmonary bypass with enoximone or steroids in patients undergoing myocardial revascularization: a preliminary report study.
    Santarpino G; Caroleo S; Onorati F; Dimastromatteo G; Abdalla K; Amantea B; Santangelo E; Gulletta E; Renzulli A
    Int J Clin Pharmacol Ther; 2009 Feb; 47(2):78-88. PubMed ID: 19203563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of enoximone in weaning from cardiopulmonary bypass following mitral valve surgery.
    Tarr TJ; Jeffrey RR; Kent AP; Cowen ME
    Cardiology; 1990; 77 Suppl 3():51-7; discussion 62-7. PubMed ID: 2148281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhabdomyolysis and acute renal failure in unsuspected malignant hyperpyrexia.
    Burns AP; Hopkins PM; Hall G; Pusey CD
    Q J Med; 1993 Jul; 86(7):431-4. PubMed ID: 8210298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal inherited rhabdomyolysis and malignant hyperthermia.
    Denborough MA; McLean A; Morgan G; Hopkinson KC
    Lancet; 1994 Jan; 343(8891):236-7. PubMed ID: 7904690
    [No Abstract]   [Full Text] [Related]  

  • 19. Enoximone versus dopamine in patients being weaned from cardiopulmonary bypass.
    Birnbaum DE; Preuner JG; Gieseke R; Trenk D; Jaehnchen E
    Cardiology; 1990; 77 Suppl 3():34-41; discussion 62-7. PubMed ID: 2148278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of phosphodiesterase inhibitors on accumulation of cyclic AMP in isolated ventricular cardiomyocytes.
    Kelso EJ; McDermott BJ; Silke B
    Biochem Pharmacol; 1995 Feb; 49(4):441-52. PubMed ID: 7872950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.